探索以基分子作为帕金森病的新疗法:综合性审查
Ritam Mondal1, Deepika Paliwal1, Aman Thakur2
1Department of Pharmacy, School of Medical & Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh.
Mini reviews in medicinal chemistry
|October 23, 2025
概括
合成醇衍生物通过向MAO,氧化应激和神经炎症等关键病理机制来治疗帕金森病 (PD) 是有前途的. 进一步的研究可能会导致创新的PD疗法.
科学领域:
- 神经科学是一个神经科学.
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特征是多巴胺基神经元的损失,导致运动和非运动症状.
- 目前PD的治疗方法主要控制症状,但不能阻止疾病的进展.
研究的目的:
- 审查合成醇衍生物作为帕金森病的潜在治疗剂.
- 分析分子标,结构-活性关系和PD中的醇化合物的治疗潜力.
- 探索计算和药物化学的进步,以增强PD的基于英多尔的治疗方法.
主要方法:
- 综合性英多尔衍生物及其对PD相关目标的活性的综合性文献综述.
- 分析醇化合物的结构-活性关系 (SAR).
- 探索用于药物设计的计算和药物化学方法.
主要成果:
- 醇衍生物对PD的关键病原性标具有强烈活性,包括单胺氧化酶 (MAO),NMDA受体,氧化应激和神经炎症.
- 合成策略和SAR研究揭示了开发新型PD治疗方法的有希望的支架.
- 计算化学的进步有助于合理设计和优化基于醇的化合物.
结论:
- 合成醇衍生物代表了一类有前途的化合物,用于开发帕金森病的创新治疗方法.
- 针对多种涉及PD病理的途径,使用以醇为基础的疗法,为疾病修饰提供了一个潜在的策略.
- 医药化学和计算方法的持续研究对于实现这些化合物的治疗潜力至关重要.
相关概念视频
01:24Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
906
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
906
01:22Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.6K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.6K